FDA Inspection
Versiti Indiana IncVersiti Indiana Inc – FDA Inspection, Mar 22, 2013
Record Details
This FDA Inspection record concerns Versiti Indiana Inc, with an inspection on March 22, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Versiti Indiana Inc
- Inspection Date
- March 22, 2013
- Product Type
- Biologics
View Company Profile
ID · 5a000528-f70f-45f6-bec3-0f2fc49c465e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 823562
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.171Biological product deviation report
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Versiti Indiana Inc
9| Date | Classification | Office | Project area |
|---|---|---|---|
| August 8, 2024 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| November 2, 2021 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| June 29, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 21, 2016 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| March 5, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Versiti Indiana Inc
- FDA Inspection 1247804 - 2024-08-08
- FDA Inspection 1156373 - 2021-11-02
- FDA Inspection 1058469 - 2018-06-29
- FDA Inspection 985159 - 2016-09-21
- FDA Inspection 868604 - 2014-03-05
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.